Target intelligence / Profile preview

Dendritic Cells (Activated) (DCs (Activated))

Target
DCs (Activated)
Molecular classification
Antigen-Presenting Cell, Immune Cell, Myeloid Cell
01

Overview

Dendritic cells (DCs) are professional antigen-presenting cells crucial for initiating and regulating adaptive immune responses. Upon activation by antigens and danger signals, DCs mature, upregulate MHC and co-stimulatory molecules, and migrate to lymph nodes to activate T cells. Enhanced antigen presentation by DCs is a key strategy in vaccine development and cancer immunotherapy to elicit robust T cell responses.

Other names
Activated Dendritic CellsMature Dendritic CellsAntigen-Presenting Dendritic Cells
02

Mechanism of action

Drugs enhance antigen uptake, processing, and presentation by DCs, leading to increased T cell activation and immune response. Adjuvants stimulate DCs via pattern recognition receptors (PRRs) like TLRs, promoting maturation and cytokine release.

03

Biological functions

Antigen presentationT cell activationImmune response initiationCytokine secretionMigration to lymph nodes
04

Disease associations

Cancer immunotherapyVaccine developmentAutoimmune diseases (dysregulation)Infectious disease immunity
05

Safety considerations

Cytokine storm (excessive immune activation)Autoimmunity (inappropriate T cell activation)Off-target effects of adjuvantsLimited understanding of long-term effects of DC-based therapies
06

Interacting drugs

CpG oligonucleotides (TLR9 agonists)

3 more in the full profile.

07

Biomarkers

MHC Class I expressionMHC Class II expressionCD80 (B7-1)CD86 (B7-2)CD40IL-12 secretionType I IFN secretionDC migration markers (e.g., CCR7)

Beyond the preview

Go deeper on Dendritic Cells (Activated) (DCs (Activated)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dendritic Cells (Activated) (DCs (Activated)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call